Intra-Cellular Therapies Statistics
Total Valuation
AGNC Investment has a market cap or net worth of $9.88 billion.
Important Dates
The next estimated earnings date is Monday, October 20, 2025.
| Earnings Date | Oct 20, 2025 |
| Ex-Dividend Date | Jul 1, 2025 |
Share Statistics
AGNC Investment has 1.04 billion shares outstanding. The number of shares has increased by 32.54% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.04B |
| Shares Change (YoY) | +32.54% |
| Shares Change (QoQ) | +10.35% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.03B |
Valuation Ratios
The trailing PE ratio is 41.85 and the forward PE ratio is 6.07.
| PE Ratio | 41.85 |
| Forward PE | 6.07 |
| PS Ratio | 19.91 |
| Forward PS | 6.87 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.56 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26, with a Debt / Equity ratio of 6.70.
| Current Ratio | 0.26 |
| Quick Ratio | 0.24 |
| Debt / Equity | 6.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.98%.
| Return on Equity (ROE) | 3.98% |
| Return on Assets (ROA) | 0.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $9.36M |
| Profits Per Employee | $4.45M |
| Employee Count | 53 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.21% in the last 52 weeks. The beta is 1.27, so AGNC Investment's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | -0.21% |
| 50-Day Moving Average | 24.86 |
| 200-Day Moving Average | 24.98 |
| Relative Strength Index (RSI) | 56.96 |
| Average Volume (20 Days) | 8,881 |
Short Selling Information
The latest short interest is 12,245, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 12,245 |
| Short Previous Month | 38,295 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
In the last 12 months, AGNC Investment had revenue of $496.00 million and earned $236.00 million in profits. Earnings per share was $0.26.
| Revenue | 496.00M |
| Gross Profit | 496.00M |
| Operating Income | 378.00M |
| Pretax Income | n/a |
| Net Income | 236.00M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $22.17 billion in cash and $69.32 billion in debt, giving a net cash position of -$47.15 billion or -$45.26 per share.
| Cash & Cash Equivalents | 22.17B |
| Total Debt | 69.32B |
| Net Cash | -47.15B |
| Net Cash Per Share | -$45.26 |
| Equity (Book Value) | 10.35B |
| Book Value Per Share | 8.36 |
| Working Capital | -67.73B |
Full Balance SheetCash Flow
| Operating Cash Flow | 458.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 76.21% and 76.21%.
| Gross Margin | 100.00% |
| Operating Margin | 76.21% |
| Pretax Margin | 76.21% |
| Profit Margin | 76.21% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
